Literature DB >> 33290151

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2020        PMID： 33290151      PMCID： PMC7733884          DOI： 10.1080/21645515.2020.1851114

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  7 in total

1.  Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.

Authors:  Grégoire de Streel; Charlotte Bertrand; Nicolas Chalon; Stéphanie Liénart; Orian Bricard; Sara Lecomte; Julien Devreux; Mélanie Gaignage; Gitte De Boeck; Lore Mariën; Inge Van De Walle; Bas van der Woning; Michael Saunders; Hans de Haard; Elien Vermeersch; Wim Maes; Hans Deckmyn; Pierre G Coulie; Nicolas van Baren; Sophie Lucas
Journal:  Nat Commun       Date:  2020-09-11       Impact factor: 14.919

2.  Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.

Authors:  Karim Fizazi; Charles G Drake; Tomasz M Beer; Eugene D Kwon; Howard I Scher; Winald R Gerritsen; Alberto Bossi; Alfons J M van den Eertwegh; Michael Krainer; Nadine Houede; Ricardo Santos; Hakim Mahammedi; Siobhan Ng; Riccardo Danielli; Fabio A Franke; Santhanam Sundar; Neeraj Agarwal; André M Bergman; Tudor E Ciuleanu; Ernesto Korbenfeld; Lisa Sengeløv; Steinbjorn Hansen; M Brent McHenry; Allen Chen; Christopher Logothetis
Journal:  Eur Urol       Date:  2020-08-15       Impact factor: 20.096

3.  Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.

Authors:  Thomas Powles; Se Hoon Park; Eric Voog; Claudia Caserta; Begoña P Valderrama; Howard Gurney; Haralabos Kalofonos; Siniša Radulović; Wim Demey; Anders Ullén; Yohann Loriot; Srikala S Sridhar; Norihiko Tsuchiya; Evgeny Kopyltsov; Cora N Sternberg; Joaquim Bellmunt; Jeanny B Aragon-Ching; Daniel P Petrylak; Robert Laliberte; Jing Wang; Bo Huang; Craig Davis; Camilla Fowst; Nuno Costa; John A Blake-Haskins; Alessandra di Pietro; Petros Grivas
Journal:  N Engl J Med       Date:  2020-09-18       Impact factor: 91.245

4.  Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.

Authors:  Evangelos J Giamarellos-Bourboulis; Maria Tsilika; Simone Moorlag; Nikolaos Antonakos; Antigone Kotsaki; Jorge Domínguez-Andrés; Evdoxia Kyriazopoulou; Theologia Gkavogianni; Maria-Evangelia Adami; Georgia Damoraki; Panagiotis Koufargyris; Athanassios Karageorgos; Amalia Bolanou; Hans Koenen; Reinout van Crevel; Dionyssia-Irene Droggiti; George Renieris; Antonios Papadopoulos; Mihai G Netea
Journal:  Cell       Date:  2020-09-01       Impact factor: 41.582

5.  A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing.

Authors:  Wen-Wei Zhang; Subir Karmakar; Sreenivas Gannavaram; Ranadhir Dey; Patrick Lypaczewski; Nevien Ismail; Abid Siddiqui; Vahan Simonyan; Fabiano Oliveira; Iliano V Coutinho-Abreu; Thiago DeSouza-Vieira; Claudio Meneses; James Oristian; Tiago D Serafim; Abu Musa; Risa Nakamura; Noushin Saljoughian; Greta Volpedo; Monika Satoskar; Sanika Satoskar; Pradeep K Dagur; J Philip McCoy; Shaden Kamhawi; Jesus G Valenzuela; Shinjiro Hamano; Abhay R Satoskar; Greg Matlashewski; Hira L Nakhasi
Journal:  Nat Commun       Date:  2020-07-10       Impact factor: 14.919

6.  Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

Authors:  Paul L Reiter; Michael L Pennell; Mira L Katz
Journal:  Vaccine       Date:  2020-08-20       Impact factor: 3.641

7.  Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.

Authors:  Anthony K Park; Yuman Fong; Sang-In Kim; Jason Yang; John P Murad; Jianming Lu; Brook Jeang; Wen-Chung Chang; Nanhai G Chen; Sandra H Thomas; Stephen J Forman; Saul J Priceman
Journal:  Sci Transl Med       Date:  2020-09-02       Impact factor: 19.319
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.